ATLANTA — Allergan CEO David E.I. Pyott, MBA, gave the inaugural Visionary Lecture today at the American Society for Dermatologic Surgery’s annual meeting.
Pyott described the timeline and milestones of Allergan’s medical aesthetics business. In the late 1980s Allergan’s CEO Gavin Herbert purchased Botox, then classified as an orphan drug, for less than $30 million, and at that time annual Botox sales were only about $5 million, Pyott said.
David E. I.More »